Keyphrases
Stereotactic Radiosurgery
100%
Colorectal Cancer
88%
Tumor
48%
Gastric Cancer
43%
Gamma Knife Radiosurgery
43%
Overall Survival
39%
Colorectal Cancer Patients
37%
Taiwan
33%
Brain Metastases
32%
Metastatic Colorectal Cancer (mCRC)
32%
Radiosurgery
30%
Arteriovenous Malformation
28%
Prognostic Factors
24%
Gastric Cancer Patients
24%
International multicenter Study
21%
Multivariate Analysis
21%
Brain Arteriovenous Malformation (bAVM)
20%
Microsatellite Instability-high (MSI-H)
19%
Taipei
18%
Curative Surgery
18%
Lymph Node Metastasis
18%
Carcinoembryonic Antigen
17%
5-year Survival
17%
General Hospital
17%
Chemotherapy
17%
Overexpression
16%
Disease-free Survival
16%
Cerebral Arteriovenous Malformation
16%
Colon Cancer
15%
Hazard Ratio
15%
Resection
15%
Obliteration
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Magnetic Resonance Imaging
14%
Confidence Interval
13%
Patients with Colorectal Cancer
13%
Independent Prognostic Factor
12%
Carcinoembryonic Antigen Levels
12%
5-fluorouracil (5-FU)
12%
Curative Resection
12%
Risk Factors
12%
Poor Prognosis
12%
Dural Arteriovenous Fistula (dAVF)
11%
Clinical Significance
11%
Carcinoma
11%
Surgical Outcomes
11%
Vestibular Schwannoma
10%
Tumor Volume
10%
Prognostic Value
10%
National Cohort Study
10%
Clinical Papers
10%
Distant Metastasis
10%
Tumor Size
10%
Colorectal Cancer Cells
10%
Genetic Modification
10%
Clinical Outcomes
9%
Gastric Carcinoma
9%
Completely Resected
9%
Lung Adenocarcinoma
9%
Gastric Adenocarcinoma
9%
Stomach
9%
Metastasis
9%
Tumor Recurrence
9%
Liver Metastasis
9%
High Risk
9%
Meningioma
8%
Local Tumor Control
8%
Leucovorin
8%
Surgical Resection
8%
Prognostic Significance
8%
Lymphovascular Invasion
8%
Colon Cancer Cells
8%
Patient Survival
8%
Multi-institutional Study
8%
Tumor Control
7%
Univariate Analysis
7%
Progression-free Survival
7%
Tumor Cells
7%
After Surgery
7%
Oxaliplatin
7%
Survival Rate
7%
Digital Subtraction Angiography
7%
Right-sided Colon Cancer
7%
Odds Ratio
7%
Treatment Outcome
7%
Overall Survival Rate
7%
Prognostic Indicator
6%
Young Patients
6%
Polymorphism
6%
Transanal Total Mesorectal Excision (taTME)
6%
Adverse Radiation Effect
6%
Embolization
6%
Gastrectomy
6%
Colorectal Carcinoma
6%
FOLFOX
6%
Mortality Rate
6%
Intracranial Dural Arteriovenous Fistula
6%
Meta-analysis
6%
Repeat Stereotactic Radiosurgery
6%
Taiwanese
6%
Medicine and Dentistry
Neoplasm
90%
Stereotactic Radiosurgery
86%
Colorectal Carcinoma
78%
Abdominal Cancer
56%
Surgery
45%
Overall Survival
43%
Recurrent Disease
34%
Prognostic Factor
30%
Brain Metastasis
29%
Arteriovenous Malformation
28%
Diseases
27%
Bleeding
26%
Metastatic Carcinoma
25%
Radiosurgery
25%
Colon Carcinoma
22%
Rectum Cancer
22%
Gamma Knife Radiosurgery
21%
Survival Rate
20%
Cohort Analysis
20%
Gastrectomy
20%
Lymph Node Metastasis
20%
Cerebral Arteriovenous Malformation
19%
Disease Free Survival
17%
Carcinoembryonic Antigen
16%
Malignant Neoplasm
16%
Multivariate Analysis
15%
Lung Cancer
14%
Lymph Node
13%
Dural Arteriovenous Fistula
13%
Non Small Cell Lung Cancer
12%
Breast Cancer
12%
Chemoradiotherapy
11%
Hazard Ratio
11%
Magnetic Resonance Imaging
10%
Retrospective Study
10%
Lung Adenocarcinoma
10%
Meningioma
10%
Carcinoma
9%
Liver Metastasis
9%
Gene Mutation
9%
Cancer Cell
9%
Cancer
8%
Proportional Hazards Model
8%
Laparoscopic Surgery
8%
Free Tissue Graft
8%
Microsatellite Instability
7%
Stomach Carcinoma
7%
Embolization
7%
Distant Metastasis
7%
Radiation Therapy
7%
Metastasectomy
7%
Stomach Adenocarcinoma
7%
Lymphovascular Invasion
7%
Carcinogenesis
7%
Adenocarcinoma
7%
Vestibular Schwannoma
7%
Progression Free Survival
6%
Metastatic Colorectal Cancer
6%
Total Mesorectal Excision
6%
Primary Tumor
6%
Tumor Recurrence
6%
Retroperitoneal Lymph Node Dissection
6%
Tumor Progression
6%
Mortality Rate
6%
Univariate Analysis
6%
Pediatrics
6%
Apoplexy
6%
In Vitro
6%
Cavernous Sinus
6%
Odds Ratio
5%
Meta-Analysis
5%
Tumor Cell
5%
Retrospective Cohort Study
5%
Randomized Controlled Trial
5%
Epidermal Growth Factor Receptor
5%
Pneumonectomy
5%
Intracranial Tumor
5%
Colorectal Surgery
5%
Quality of Life
5%
Radiation Response
5%
Biological Marker
5%
Colon
5%
Squamous Cell Carcinoma
5%
Radiation Necrosis
5%
Fasciocutaneous Flap
5%